New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:22 EDTMDT, BCRC.R. Bard Lutonix balloon has 50% chance for approval at best, says Wells Fargo
After reviewing briefing materials posted to the FDA's website for an upcoming advisory committee meeting, Wells Fargo said it expects a "very tough" panel for C.R. Bard's (BCR) Lutonix drug-coated balloon and puts the chance of approval for the product at 50% "at best." Additionally, the firm does not think Bard's data is competitive with stents, which are the standard of care, or with data on Medtronic's (MDT) competing balloon.
News For BCR;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
14:28 EDTMDTMedtronic volatility elevated into Q1 and outlook
Medtronic September call option implied volatility is at 49, September and October is at 26; compared to its 52-week range of 13 to 38, suggesting large near term price movement into the expected release of Q1 results on September 3.
07:10 EDTMDTMedtronic study detects gene associated with sudden cardiac death
Subscribe for More Information
August 27, 2015
10:00 EDTBCROn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTBCROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:09 EDTBCRC.R. Bard initiated with a Sector Weight at KeyBanc
Subscribe for More Information
06:14 EDTBCRC.R. Bard upgraded to Buy from Neutral at Goldman
Subscribe for More Information
August 25, 2015
09:07 EDTMDTMedtronic to acquire Twelve for $458M
In support of the company's therapy innovation strategy, Medtronic announced that it has signed a definitive agreement to acquire Twelve, a medical device company focused on the development of a transcatheter mitral valve replacement, or TMVR device. Twelve is the twelfth company spun out from the premier medical device incubator The Foundry. Medtronic has agreed to pay up to $458M for Twelve including $408M at closing and $50M on achievement of CE Marking. The cash- and debt-free transaction remains subject to customary closing conditions, and is expected to close in October 2015.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use